235 related articles for article (PubMed ID: 20585842)
21. Ursolic Acid Nanocrystals for Dissolution Rate and Bioavailability Enhancement: Influence of Different Particle Size.
Pi J; Liu Z; Wang H; Gu X; Wang S; Zhang B; Luan H; Zhu Z
Curr Drug Deliv; 2016; 13(8):1358-1366. PubMed ID: 26953239
[TBL] [Abstract][Full Text] [Related]
22. Influence of microcrystal formulation on in vivo absorption of celecoxib in rats.
Nasr M
AAPS PharmSciTech; 2013 Jun; 14(2):719-26. PubMed ID: 23543607
[TBL] [Abstract][Full Text] [Related]
23. Preparation and in vitro/in vivo evaluation of revaprazan hydrochloride nanosuspension.
Li W; Yang Y; Tian Y; Xu X; Chen Y; Mu L; Zhang Y; Fang L
Int J Pharm; 2011 Apr; 408(1-2):157-62. PubMed ID: 21295124
[TBL] [Abstract][Full Text] [Related]
24. Improvement of the dissolution rate of nitrendipine using a new pulse combustion drying method.
Wang L; Cui FD; Sunada H
Chem Pharm Bull (Tokyo); 2007 Aug; 55(8):1119-25. PubMed ID: 17666831
[TBL] [Abstract][Full Text] [Related]
25. Nanonization of itraconazole by high pressure homogenization: stabilizer optimization and effect of particle size on oral absorption.
Sun W; Mao S; Shi Y; Li LC; Fang L
J Pharm Sci; 2011 Aug; 100(8):3365-3373. PubMed ID: 21520089
[TBL] [Abstract][Full Text] [Related]
26. Enhance the dissolution rate and oral bioavailability of pranlukast by preparing nanosuspensions with high-pressure homogenizing method.
Wang L; Hao Y; Liu N; Ma M; Yin Z; Zhang X
Drug Dev Ind Pharm; 2012 Nov; 38(11):1381-9. PubMed ID: 22300415
[TBL] [Abstract][Full Text] [Related]
27. Development of Nanonized Nitrendipine and Its Transformation into Nanoparticulate Oral Fast Dissolving Drug Delivery System.
Gandhi NV; Deokate UA; Angadi SS
AAPS PharmSciTech; 2021 Mar; 22(3):113. PubMed ID: 33751276
[TBL] [Abstract][Full Text] [Related]
28. Investigation of nanosized crystalline form to improve the oral bioavailability of poorly water soluble cilostazol.
Miao X; Sun C; Jiang T; Zheng L; Wang T; Wang S
J Pharm Pharm Sci; 2011; 14(2):196-214. PubMed ID: 21733409
[TBL] [Abstract][Full Text] [Related]
29. Microemulsion formulation for enhanced absorption of poorly soluble drugs. II. In vivo study.
Kawakami K; Yoshikawa T; Hayashi T; Nishihara Y; Masuda K
J Control Release; 2002 May; 81(1-2):75-82. PubMed ID: 11992680
[TBL] [Abstract][Full Text] [Related]
30. Formulation and Evaluation of Naringenin Nanosuspensions for Bioavailability Enhancement.
Gera S; Talluri S; Rangaraj N; Sampathi S
AAPS PharmSciTech; 2017 Nov; 18(8):3151-3162. PubMed ID: 28534300
[TBL] [Abstract][Full Text] [Related]
31. Fabrication and characterization of glimepiride nanosuspension by ultrasonication-assisted precipitation for improvement of oral bioavailability and in vitro α-glucosidase inhibition.
Rahim H; Sadiq A; Khan S; Amin F; Ullah R; Shahat AA; Mahmood HM
Int J Nanomedicine; 2019; 14():6287-6296. PubMed ID: 31496686
[TBL] [Abstract][Full Text] [Related]
32. Development of megestrol acetate solid dispersion nanoparticles for enhanced oral delivery by using a supercritical antisolvent process.
Ha ES; Kim JS; Baek IH; Yoo JW; Jung Y; Moon HR; Kim MS
Drug Des Devel Ther; 2015; 9():4269-77. PubMed ID: 26345723
[TBL] [Abstract][Full Text] [Related]
33. Preparation of a Mesoporous Structure of SnO
Liu X; Wu C; Bai A; Lv H; Xu X; Cao Y; Shang W; Hu L; Liu Y
AAPS PharmSciTech; 2018 Oct; 19(7):3228-3236. PubMed ID: 30187447
[TBL] [Abstract][Full Text] [Related]
34. Eplerenone nanocrystals engineered by controlled crystallization for enhanced oral bioavailability.
Khan MA; Ansari MM; Arif ST; Raza A; Choi HI; Lim CW; Noh HY; Noh JS; Akram S; Nawaz HA; Ammad M; Alamro AA; Alghamdi AA; Kim JK; Zeb A
Drug Deliv; 2021 Dec; 28(1):2510-2524. PubMed ID: 34842018
[TBL] [Abstract][Full Text] [Related]
35. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension.
Zhang K; Yu H; Luo Q; Yang S; Lin X; Zhang Y; Tian B; Tang X
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1285-92. PubMed ID: 23562534
[TBL] [Abstract][Full Text] [Related]
36. Improvement of dissolution and absorption properties of poorly water-soluble drug by preparing spray-dried powders with alpha-glucosyl hesperidin.
Uchiyama H; Tozuka Y; Imono M; Takeuchi H
Int J Pharm; 2010 Jun; 392(1-2):101-6. PubMed ID: 20307634
[TBL] [Abstract][Full Text] [Related]
37. Preparation of starch macrocellular foam for increasing the dissolution rate of poorly water-soluble drugs.
Zhao Y; Wu C; Zhao Z; Hao Y; Xu J; Yu T; Qiu Y; Jiang J
Pharm Dev Technol; 2016 Sep; 21(6):749-54. PubMed ID: 26166407
[TBL] [Abstract][Full Text] [Related]
38. Effect of particle size on solubility, dissolution rate, and oral bioavailability: evaluation using coenzyme Q₁₀ as naked nanocrystals.
Sun J; Wang F; Sui Y; She Z; Zhai W; Wang C; Deng Y
Int J Nanomedicine; 2012; 7():5733-44. PubMed ID: 23166438
[TBL] [Abstract][Full Text] [Related]
39. Preparation and characterization of nitrendipine solid lipid nanoparticles.
Manjunath K; Venkateswarlu V; Hussain A
Pharmazie; 2011 Mar; 66(3):178-86. PubMed ID: 21553647
[TBL] [Abstract][Full Text] [Related]
40. Fabrication of carvedilol nanosuspensions through the anti-solvent precipitation-ultrasonication method for the improvement of dissolution rate and oral bioavailability.
Liu D; Xu H; Tian B; Yuan K; Pan H; Ma S; Yang X; Pan W
AAPS PharmSciTech; 2012 Mar; 13(1):295-304. PubMed ID: 22246736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
